Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-018132
Filing Date
2013-03-20
Accepted
2013-03-20 19:07:51
Documents
2
Period of Report
2013-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd374824.html 3  
1 FORM 3 rrd374824.xml 3 3455
2 POWER OF ATTORNEY rrd336860_380495.htm EX-24.3 2288
  Complete submission text file 0001181431-13-018132.txt   7050
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE, SUITE 950 NASHVILLE TN 37203
Business Address
Herman James L (Reporting) CIK: 0001572342 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33637 | Film No.: 13706137